| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.4 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |